Skip to main content
Clinical Trials/NCT03894111
NCT03894111
Completed
Not Applicable

Prognostic Effect of Neutrophil \ Lymphocyte Ratio, Lactate Level and Apache 2 Score on Mortality in Intensive Care Trauma Patients at First Hospitalizations

Balikesir University1 site in 1 country107 target enrollmentJanuary 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
İntensive Care Unit
Sponsor
Balikesir University
Enrollment
107
Locations
1
Primary Endpoint
mortallty
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

In this study, the data of the patients who were hospitalized due to trauma in intensive care unit (ICU) were examined in their first development. The mortality rate and the factors affecting mortality in these patients were determined

Detailed Description

In this study, 107 trauma patients were examined. Patients were divided into two groups according to ICU results: survivors (Group 1) and deceased patients (Group2). Patients were rated in terms of age, Neutrophil lymphocyte ratio (NLR) , mean platelet volüme (MPV), lactat value, intensive care unit stay, APACHE 2 soring systems. Mortality rate and the factors affecting this rate were examined. 83 of the patients were male (77.58%) and 24 were female (22.42%). The mean age was 46 years. The mean value of lactate level was 3.25. MPV mean value was 10.34. NLR mean value was 8.23 and Apache 2 score mean value was 22.8. The average length of stay in hospital was 11.33 days. When the intergroup mortality was evaluated in terms of the relationship between continuous variables, there was a statistically significant difference in apache 2 score. No statistically significant difference was found between age, lactate, MPV, NRL and length of hospital stay. NRL, MPV, Lactate levels were not suitable for evaluation of trauma patients as a early prognostic factor in the first day ICU admission. The investigators think that the use of trauma scoring systems such as apache 2 related to mortality during first hospitalization in ICU is more appropriate.

Registry
clinicaltrials.gov
Start Date
January 1, 2019
End Date
March 27, 2019
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Balikesir University
Responsible Party
Principal Investigator
Principal Investigator

bülent atik

asistant prof

Balikesir University

Eligibility Criteria

Inclusion Criteria

  • trauvma patients

Exclusion Criteria

  • systemic inflammatory diseases
  • renal failure
  • cardiac failure
  • serebro vascular diseases

Outcomes

Primary Outcomes

mortallty

Time Frame: 28 days

mortallty ratio

Study Sites (1)

Loading locations...

Similar Trials